Table 2. Changes in clinical parameters before and after O3FAs supplement.
| Parameters | Before | After | Difference | P |
|---|---|---|---|---|
| Urine ACR (mg/g) | 475.8 ± 1235.9 | 385.6 ± 1067.9 | -72.1 ± 507.6 | <0.001 |
| Urine ACR, log- transformed | 4.0 ± 2.0 | 3.8 ± 2.0 | 0.003 | |
| GFR (mL/min/1.73 m2) | 76.1 ± 25.9 | 74.4 ± 27.9 | -1.8 ± 11.2 | 0.004 |
| Fasting blood glucose (mg/dL) | 141.2 ± 50.9 | 129.7 ± 36.6 | -11.5 ± 3.0 | <0.001 |
| Postprandial blood glucose (mg/dL) | 223.6 ± 84.7 | 208.2 ± 66.1 | -15.3 ± 91.4 | 0.020 |
| HbA1c (%) | 7.8 ± 6.3 | 7.1 ± 1.1 | -0.6 ± 6.3 | 0.084 |
| Total cholesterol (mg/dL) | 187.6 ± 55.9 | 158.8 ± 41.1 | -28.8 ± 55.3 | <0.001 |
| Total cholesterol, log-transformed | 5.2 ± 0.3 | 5.0 ± 0.3 | <0.001 | |
| Triglyceride (mg/dL) | 417.9 ± 646.5 | 227.4 ± 172.3 | -190.4 ± 633.1 | <0.001 |
| Triglyceride, log-transformed | 5.8 ± 0.7 | 5.2 ± 0.6 | <0.001 | |
| HDL cholesterol (mg/dL) | 41.1 ± 22.1 | 40.4 ± 12.7 | -0.7 ± 23.9 | 0.573 |
| HDL cholesterol, log-transformed | 3.7 ± 0.3 | 3.7 ± 0.3 | 0.975 | |
| Uric acid (mg/dL) | 6.02 ± 1.74 | 5.80 ± 1.59 | -0.21 ± 1.42 | 0.006 |
| hsCRP (mg/L) | 5.9 ± 14.4 | 2.4 ± 8.3 | -3.5 ± 15.3 | 0.004 |
| hsCRP, log transformed | 0.5 ± 1.4 | 0.1 ± 1.0 | <0.001 |
Data are presented as N (%) or mean ± SD. O3FA, omega-3 fatty acid; ACR, albumin to creatinine ratio; GFR, glomerular filtration rate; HbA1c, glycated hemoglobin; HDL cholesterol, high-density lipoprotein cholesterol; hsCRP, high sensitivity C-reactive protein.